This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 221853 results found since Jan 2013.
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
Condition: HIV/AIDS Interventions: Behavioral: Healthy Living Intervention (HLI); Behavioral: Standard of Care Sponsors: University of California, San Francisco; University of California, Berkeley; Makerere University; Infectious Diseases Research Collaboration, Uganda; Kenya Medical Research Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382
Condition: Human Immuno-deficiency Virus (HIV) Disease Interventions: Drug: Budigalimab; Drug: Placebo for Budigalimab; Drug: ABBV-382; Drug: Placebo for ABBV-382 Sponsor: AbbVie Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Support for Adolescents Living With HIV in South Africa
Conditions: Human Immunodeficiency Virus; HIV Interventions: Behavioral: In-person adolescent-friendly service (iPAS) intervention; Behavioral: mHealth (InTSHA) intervention; Behavioral: Standard of Care Sponsors: Emory University; University of KwaZulu; National Institute of Mental Health (NIMH) Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)
Condition: Hiv Intervention: Drug: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO] Sponsors: University Hospital, Caen; Merck Sharp & Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Oral Dronabinol-HIV
Condition: HIV Intervention: Drug: Dronabinol Capsules Sponsors: Yale University; National Institute on Drug Abuse (NIDA) Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition: HIV Interventions: Biological: N332-GT5 gp140 (IM, Bolus); Biological: N332-GT5 gp140 (IM, Fractioned); Biological: N332-GT5 gp140 (SC, Bolus); Biological: N332-GT5 gp140 (SC, Fractioned); Biological: SMNP (IM, Bolus); Biological: SMNP (IM, Fractioned); Biological: SMNP (S C, Bolus); Biological: SMNP (SC, Fractioned) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
Condition: HIV/AIDS Interventions: Behavioral: Healthy Living Intervention (HLI); Behavioral: Standard of Care Sponsors: University of California, San Francisco; University of California, Berkeley; Makerere University; Infectious Diseases Research Collaboration, Uganda; Kenya Medical Research Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition: HIV Interventions: Biological: N332-GT5 gp140 (IM, Bolus); Biological: N332-GT5 gp140 (IM, Fractioned); Biological: N332-GT5 gp140 (SC, Bolus); Biological: N332-GT5 gp140 (SC, Fractioned); Biological: SMNP (IM, Bolus); Biological: SMNP (IM, Fractioned); Biological: SMNP (S C, Bolus); Biological: SMNP (SC, Fractioned) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
Condition: HIV/AIDS Interventions: Behavioral: Healthy Living Intervention (HLI); Behavioral: Standard of Care Sponsors: University of California, San Francisco; University of California, Berkeley; Makerere University; Infectious Diseases Research Collaboration, Uganda; Kenya Medical Research Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
